)
Visual
earnings real time
PHC
PHC (6523) investor relations material
PHC Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary13 Nov, 2025
Executive summary
Operating profit forecast was revised upward by JPY 2.6 billion, with annual dividend forecast maintained, despite JPY 6.8 billion FX losses through Q2 and a net loss attributable to owners.
Revenue remained stable year-over-year, with growth in Diabetes Management and Healthcare Solutions offsetting declines in Diagnostics & Life Sciences due to FX and weak US demand.
CGM business transfer is in final negotiation stages, expected to close January 2026, with impact included in forecasts.
Interim dividend set at JPY 21 per share, with annual forecast maintained at JPY 42 per share.
Financial highlights
Interest-bearing debt decreased by JPY 7.6 billion to JPY 247.7 billion; cash and cash equivalents fell by JPY 6.3 billion in Q2.
Operating profit rose 12.7% year-on-year to JPY 10,378 million; adjusted EBITDA increased 4.2% to JPY 24,260 million.
Net cash provided by operating activities was JPY 12.1 billion; capital expenditure JPY 4.4 billion; financial cash flow outflow JPY 17.6 billion.
ROE for the quarter was 4.2%, reflecting a year-on-year decrease in profit attributable to owners.
Profit attributable to owners revised to JPY 4.4 billion, down JPY 3 billion after tax adjustments.
Outlook and guidance
Full-year revenue forecast remains at JPY 363,100 million, with operating profit revised upward to JPY 20,000 million.
FX rates assumed at JPY 171/EUR and JPY 146/USD; full-year outlook stable with unchanged dividend forecast.
No impairment loss required after recent test; risk of impairment is lower than previously.
Tariff impact for the year expected at JPY 1–1.5 billion, with mitigation measures ongoing.
Segment guidance: Diabetes Management revised upward, Healthcare Solutions and Diagnostics & Life Sciences revised downward.
Biomedical US market recovery timeline
BGM profit margin sustainability drivers
CGM transfer impact on VCP targets
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 000001
Double-digit profit growth in core segments, but banking net profit declined 3.5%. - SANB4
Net profit hit R$4.1B, ROAE 17.6%, with robust loan growth and digital innovation. - BG
Adjusted EPS was $7.57, with strong segment EBIT and stable 2026 guidance. - ATS
Q3 revenue rose 17% to $760.7M, with strong backlog and Q4 revenue guided at $710–$750M. - SWK
Gross margin and net income rose, with CAM divestiture set to reduce debt and boost 2026 outlook. - PMI
FDA-approved artificial heart maker registers 17M shares for resale amid ongoing losses and risks. - ARCC
FY 2025 net income was $1,299M, with a $0.48/share Q1 2026 dividend declared. - SDST
Development-stage lithium refiner registers shares for resale amid high risk and capital needs. - DAC
Q2 2025 saw revenue growth, high charter coverage, and strong liquidity despite rising costs. - OCSL
Net investment income was $36.7M ($0.42/share) as NAV fell to $16.30 and a $0.40 dividend was declared.
Next PHC earnings date
Q3 202612 Feb, 2026
PHC
Next PHC earnings date
Q3 202612 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
PHC Holdings Corporation is a healthcare technology company specializing in medical devices, diagnostics, and life sciences solutions. The company develops and manufactures products such as blood glucose monitoring systems, insulin delivery devices, biomedical laboratory equipment, and diagnostics for disease management. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange (TSE).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage